California State Teachers Retirement System Sage Therapeutics, Inc. Transaction History

California State Teachers Retirement System

$78.8 Billion
Q1 2025

A detailed history of California State Teachers Retirement System transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, California State Teachers Retirement System holds 4,034 shares of SAGE stock, worth $26,342. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,034

Previous 43,352 90.69%

Holding current value

$26,342

Previous $235,000 86.38%

% of portfolio

0.0%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$5.55 - $8.66 $218,214 - $340,493	-39,318 Reduced 90.69%	4,034 $32,000
Q3 2024 Nov 14, 2024	SELL	$7.02 - $13.08 $9,989 - $18,612	-1,423 Reduced 3.18%	43,352 $312,000
Q2 2024 Apr 08, 2025	BUY	$10.58 - $17.9 $15,055 - $25,471	1,423 Added 3.28%	44,775 $486,000
Q2 2024 Aug 14, 2024	SELL	$10.58 - $17.9 $96,584 - $163,409	-9,129 Reduced 16.94%	44,775 $486,000
Q1 2024 May 15, 2024	SELL	$18.62 - $26.95 $51,968 - $75,217	-2,791 Reduced 4.92%	53,904 $1.01 Million
Q4 2023 Feb 13, 2024	SELL	$17.1 - $22.26 $42,835 - $55,761	-2,505 Reduced 4.23%	56,695 $1.23 Million
Q3 2023 Nov 14, 2023	SELL	$16.75 - $48.98 $95,140 - $278,206	-5,680 Reduced 8.75%	59,200 $1.22 Million
Q2 2023 Aug 21, 2023	SELL	$40.65 - $59.54 $62,601 - $91,691	-1,540 Reduced 2.32%	64,880 $3.05 Million
Q1 2023 May 09, 2023	SELL	$37.27 - $46.57 $34,027 - $42,518	-913 Reduced 1.36%	66,420 $2.79 Million
Q4 2022 Feb 14, 2023	BUY	$32.2 - $43.61 $32,876 - $44,525	1,021 Added 1.54%	67,333 $2.57 Million
Q3 2022 Nov 18, 2022	SELL	$32.28 - $43.27 $34,152 - $45,779	-1,058 Reduced 1.57%	66,312 $2.6 Million
Q2 2022 Aug 15, 2022	BUY	$27.52 - $37.99 $2,449 - $3,381	89 Added 0.13%	67,370 $2.18 Million
Q1 2022 May 16, 2022	SELL	$30.71 - $45.71 $175,569 - $261,324	-5,717 Reduced 7.83%	67,281 $2.23 Million
Q4 2021 Feb 15, 2022	SELL	$37.06 - $47.11 $532,626 - $677,064	-14,372 Reduced 16.45%	72,998 $3.11 Million
Q3 2021 Nov 15, 2021	SELL	$40.26 - $57.37 $3,100 - $4,417	-77 Reduced 0.09%	87,370 $3.87 Million
Q2 2021 Aug 16, 2021	SELL	$54.88 - $79.29 $99,113 - $143,197	-1,806 Reduced 2.02%	87,447 $4.97 Million
Q1 2021 May 18, 2021	SELL	$70.65 - $96.76 $13,070 - $17,900	-185 Reduced 0.21%	89,253 $6.68 Million
Q4 2020 Feb 16, 2021	BUY	$58.41 - $89.06 $76,283 - $116,312	1,306 Added 1.48%	89,438 $7.74 Million
Q3 2020 Nov 17, 2020	BUY	$41.13 - $62.45 $58,445 - $88,741	1,421 Added 1.64%	88,132 $5.39 Million
Q2 2020 Aug 17, 2020	SELL	$25.95 - $43.15 $337 - $560	-13 Reduced 0.01%	86,711 $3.61 Million
Q1 2020 May 13, 2020	SELL	$26.15 - $77.24 $59,726 - $176,416	-2,284 Reduced 2.57%	86,724 $2.49 Million
Q4 2019 Feb 14, 2020	BUY	$60.18 - $154.77 $469,343 - $1.21 Million	7,799 Added 9.6%	89,008 $6.43 Million
Q3 2019 Nov 15, 2019	BUY	$140.29 - $189.96 $135,941 - $184,071	969 Added 1.21%	81,209 $11.4 Million
Q2 2019 Aug 14, 2019	BUY	$157.85 - $183.09 $504,646 - $585,338	3,197 Added 4.15%	80,240 $14.7 Million
Q1 2019 May 09, 2019	BUY	$89.33 - $163.65 $492,565 - $902,366	5,514 Added 7.71%	77,043 $12.3 Million
Q4 2018 Feb 13, 2019	BUY	$81.94 - $139.71 $132,251 - $225,491	1,614 Added 2.31%	71,529 $6.85 Million
Q3 2018 Nov 14, 2018	SELL	$138.11 - $169.04 $3,452 - $4,226	-25 Reduced 0.04%	69,915 $9.88 Million
Q2 2018 Aug 14, 2018	BUY	$140.36 - $175.76 $813,105 - $1.02 Million	5,793 Added 9.03%	69,940 $10.9 Million
Q1 2018 May 15, 2018	BUY	$152.15 - $192.33 $686,500 - $867,792	4,512 Added 7.57%	64,147 $10.3 Million
Q4 2017 Feb 14, 2018	BUY	$60.72 - $167.34 $261,460 - $720,566	4,306 Added 7.78%	59,635 $9.82 Million
Q3 2017 Nov 13, 2017	BUY	$61.4 - $88.52 $3.4 Million - $4.9 Million	55,329	55,329 $3.45 Million

Others Institutions Holding SAGE

# of Institutions

217

Shares Held

49.9M

Call Options Held

220K

Put Options Held

312K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $388M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.

Account

California State Teachers Retirement System Sage Therapeutics, Inc. Transaction History